SARS-CoV-2 binds to angiotensin-converting enzyme 2 (ACE2) receptors, disrupting RAS balance and potentially leading to endothelial dysfunction, vascular inflammation, and heightened thrombotic risk [14,15]. Here, ACE2 is linked to endothelial dysfunction.